Survival of AIDS patients in Croatia prior to the introduction of combined antiretroviral therapy with protease inhibitors

Begovac, Josip; Kniewald, Tihana; Ugarković, N.; Lisić, Miroslav; Sonicki, Z.; Jazbec, Anamarija

doi:10.1023/A:1026750117804

Pregled bibliografske jedinice broj: 897226

Survival of AIDS patients in Croatia prior to the introduction of combined antiretroviral therapy with protease inhibitors

Begovac, Josip; Kniewald, Tihana; Ugarković, N.; Lisić, Miroslav; Sonicki, Z.; Jazbec, Anamarija

Survival of AIDS patients in Croatia prior to the introduction of combined antiretroviral therapy with protease inhibitors // European journal of epidemiology, 16 (2000), 8; 741-744 doi:10.1023/A:1026750117804 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 897226 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Survival of AIDS patients in Croatia prior to the introduction of combined antiretroviral therapy with protease inhibitors

Autori
Begovac, Josip ; Kniewald, Tihana ; Ugarković, N. ; Lisić, Miroslav ; Sonicki, Z. ; Jazbec, Anamarija

Izvornik
European journal of epidemiology (0393-2990) 16 (2000), 8; 741-744

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
AIDS ; Croatia ; CD4+ ; antiretroviral therapy

Sažetak
We report our experience on survival of adults with AIDS, treated at the University Hospital of Infectious Diseases, Zagreb, Croatia from October 1986 to December 1998. The median survival of our 116 patients was 15.8 months. Multivariate analysis showed that factors independently associated with survival were type of presenting AIDS indicator disease and CD4+ cell count.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA

Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Nastavni zavod za javno zdravstvo "Dr. Andrija Štampar",
Klinika za infektivne bolesti "Dr Fran Mihaljević"

Profili:

Anamarija Jazbec (autor)